These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23778174)

  • 21. A controlled trial of initial antiviral regimens for HIV-1 infection.
    Parienti JJ
    N Engl J Med; 2010 Mar; 362(9):854; author reply 855. PubMed ID: 20200393
    [No Abstract]   [Full Text] [Related]  

  • 22. Coverage, context and targeted prevention: optimising our impact.
    Aral SO; Cates W
    Sex Transm Infect; 2013 Jun; 89(4):336-40. PubMed ID: 23270932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European CHMP issues positive opinion for Atripla.
    AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of antiretroviral therapy on HIV reservoirs in elite controllers.
    Chun TW; Shawn Justement J; Murray D; Kim CJ; Blazkova J; Hallahan CW; Benko E; Costiniuk CT; Kandel G; Ostrowski M; Kaul R; Moir S; Casazza JP; Koup RA; Kovacs C; Fauci AS
    J Infect Dis; 2013 Nov; 208(9):1443-7. PubMed ID: 23847057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune reconstitution inflammatory syndrome associated with eosinophilic pustular folliculitis in an HIV-infected patient].
    Springinsfeld G; Roth B; Martinot M; Tortel MC; Batard ML
    Med Mal Infect; 2011 Jan; 41(1):49-50. PubMed ID: 21050684
    [No Abstract]   [Full Text] [Related]  

  • 26. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 27. Experience with tenofovir disoproxil fumarate for antiretroviral therapy.
    Stephan C
    Expert Opin Pharmacother; 2008 May; 9(7):1197-209. PubMed ID: 18422476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
    Gallant JE; Koenig E; Andrade-Villanueva J; Chetchotisakd P; DeJesus E; Antunes F; Arastéh K; Moyle G; Rizzardini G; Fehr J; Liu Y; Zhong L; Callebaut C; Szwarcberg J; Rhee MS; Cheng AK
    J Infect Dis; 2013 Jul; 208(1):32-9. PubMed ID: 23532097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era.
    De Clercq E
    Biochem Pharmacol; 2012 Aug; 84(3):241-8. PubMed ID: 22504027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
    Estebanez M; Stella-Ascariz N; Ruiz-Carrascoso G; Zamora FX; García-Bujalance S; Bernardino JI; Pérez-Valero I; Martin-Quirós A; Mingorance J; Arribas JR
    AIDS; 2013 Jan; 27(1):141-4. PubMed ID: 22914581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism].
    Ho NA; Schmidt RE; Behrens G
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1171-4. PubMed ID: 20514596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What they say about: nucleotide drugs.
    Posit Aware; 2000; 11(1):55. PubMed ID: 11366352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.
    Pavie J; Porcher R; Torti C; Medrano J; Castagna A; Valin N; Rusconi S; Ammassari A; Ghosn J; Delaugerre C; Molina JM;
    J Antimicrob Chemother; 2011 Oct; 66(10):2372-8. PubMed ID: 21821627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New fixed combination for HIV therapy].
    Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
    [No Abstract]   [Full Text] [Related]  

  • 36. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
    Warpakowski A
    MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA notifications. Updated Atripla label approved.
    AIDS Alert; 2010 Mar; 25(3):36. PubMed ID: 20629262
    [No Abstract]   [Full Text] [Related]  

  • 38. Compassionate use for tenofovir.
    AIDS Patient Care STDS; 2000 Feb; 14(2):101-2. PubMed ID: 10743524
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicines Control Council and registration backlog of antiretrovirals.
    Gosling J
    S Afr Med J; 2007 Apr; 97(4):232. PubMed ID: 17446940
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase.
    Kagan RM; Lee TS; Ross L; Lloyd RM; Lewinski MA; Potts SJ
    Antiviral Res; 2007 Sep; 75(3):210-8. PubMed ID: 17442410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.